<div id="readability-page-1">Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from $95. The shares were still rated as a buy by analyst Kyle Mikson. As noted by Canaccord, the sector momentum that […]</div>

<p>Canaccord 已将 Tempus AI, Inc.（NASDAQ:TEM）的目标股价从 95 美元下调至 80 美元，同时维持对该股票的 “买入” 评级。根据 TheFly 在 2025 年 12 月 22 日的报告，Tempus AI 被认为是值得投资的 12 大基因组股票之一</p>

Canaccord 下调了 Tempus AI, Inc. (TEM) 的目标价格